Full-length biologically active cDNAs ofbrome mosaic virus genomic RNAs 1, 2 and 3 were constructed by joining cDNA fragments. The cDNAs were constructed so that, at the 5' ends, unique SnaBI sites were present at the site of initiation of transcription. The cDNAs were inserted between a modified cauliflower mosaic virus (CaMV) 35S RNA promoter and terminator regions derived from CaMV DNA, and cloned into pUC18. When a mixture of the plasmid DNAs was inoculated onto Chenopodium hybridum leaves, local lesions appeared 5 to 6 days later. However, no symptoms appeared in similarly inoculated barley plants. Plasmid cDNAs with extra sequences at the 5' end were infectious but RNAs transcribed from cDNAs with similar sequences were not.
Introduction
Brome mosaic virus (BMV) has a tripartite genome of positive-sense RNAs, designated RNA 1, RNA 2 and RNA 3 in order of decreasing Mr (Lane, 1981) ; the nucleotide sequence of each RNA is known (Ahlquist et al., 1981 (Ahlquist et al., , 1984a . In vitro transcripts synthesized by bacterial RNA polymerase from cDNAs of BMV RNAs linked to the Pr promoter were infectious to barley plants (Ahlquist et al., 1984b) . Moreover, it has been reported that infectious RNA can be transcribed by unknown promoters from cDNA copies of viral RNA inserted into bacteriaLplasmids (Taniguchi et al., 1978; Racaniello & Baltimore, 1981; Cress etal., 1983; van Emmelo et al., 1987) . We have constructed plasmids containing BMV cDNA linked to the cauliflower mosaic virus (CaMV) 35S RNA and T7 promoters and tested their infectivity. In this paper, we compare the infectivities of cDNA plasmids and in vitro transcripts of cDNA linked to the T7 promoter, and discuss the significance of such a cDNA plasmid system in virus research.
Methods
cDNA construction of genomic RNAs. BMV (ATCC66) RNA was extracted from the purified virus as described by Okuno & Furusawa (1979) . The full-length cDNAs of BMV RNAs 1, 2 and 3 were constructed from cDNA fragments corresponding to each BMV RNA as shown in Fig. 1 . Plasmids pBl #4021, pB2#4161 and pB3#875 were obtained from Dr. M. Horikoshi and both pBl#5161 and pB2#6161 were synthesized by the method of Gubler & Hoffman (1983) using synthetic oligonucleotide primers. Almost all of the central part of each RNA sequence was represented in pBl#4021 and 0000-9796 © 1991 SGM pBl#5161 for RNA1, pB2#4161 and pB2#6161 for RNA2 and pB3 # 875 for RNA3. To obtain cDNA clones containing a Tthl 11I site with the cleavage position coincident with the 3' end of the BMV RNA cDNA sequences, a 20 base synthetic oligonucleotide 5' pd(GACCT-GGTCTCTTTTAGAGA) was used as a primer; this is complementary to 16 nucleotides of the 3' end of each genomic RNA. After each genomic RNA had been separated by electrophoresis in a low-melting point agarose gel, double-stranded cDNA was synthesized by the method of Maniatis et al. (1982) . The products corresponding to BMV RNAs 1, 2 and 3 were inserted into pUC9 at the Pstl site using oligo(dG)-oligo(dC) tailing (Maniatis et al., 1982) , creating pBTI, pBT2 and pBT3, respectively. Both pBTI and pBT2 were cut with Tthl 1 lI and PstI, and pBT3 was cut with Tthl 1 lI alone. Both ends of each cDNA insert obtained were made blunt and inserted in the Sinai site of pUC9, followed by restriction analysis to identify the orientation of the cDNA inserts. Theresultant plasmids were designated pBT11, pBT21 and pBT31. Thus, the sequences surrounding the transcription termination sites in each clone were the same as that reported by Ahlquist & Janda (1984) . To obtain cDNA clones containing a SnaBI site with the cleavage position coincident with the 5' end of the BMVspecific cDNA sequence, synthetic oligonucleotides which corresponded to the 5'-terminal 21 nucleotides of each genomic RNA sequence and which generated a SnaBI restriction site were used as primers. After primer-directed cDNA synthesis, synthetic oligonucleotides 5' pd(CCTACGTAGACCACGGAACGAGGTTC) (for RNA I), 5' pd(CCTACGTAAACCACGGAACGAGGTTC) (for RNA 2) and 5' pd(CCTACGTAAAATACCAACTAATTCT) (for RNA 3) were used to prime second-strand synthesis, creating pB 1CSI, pB2NS and pB3CS, respectively. The full-length cDNAs of RNAs 1, 2 and 3 were cloned into pUC9 after joining fragments for pBT11, pB 1 # 4021, pBl#5161 and pB1CS1 to create pBBI, fragments from pBT21, pB2 # 4161, pB2 # 6161 and pB2NS to create pBB2 and fragments from pBT31, pB3#875 and pB3CS to create pBB3 (Fig. 1) .
Construction of pBTF1, 2 and 3. Synthetic oligonucleotides 5" pd-(CTAGATGCATATAGTGAGTCGTATTAATTTA) and 5' pd-(AGCTTAAATTAATACGACTCACTATATGCAT) were annealed and the resulting DNA fragment, which contained the T7 promoter sequence and an NsiI recognition site, was inserted into the HindlII and XbaI sites ofpUCl8, creating pUCT7, pUCT7 was cut with NsiI, made blunt-ended with T4 DNA polymerase and cut with EcoRI. The resulting plasmid was ligated with the SnaBl/EcoRI fragment of the cDNA insert from pBB 1, 2 or 3, creating pBTF 1, 2 and 3, respectively ( Fig. 2) .
Construction of pCaP35.
The Sail and Pstl sites of pUC9 were eliminated by Hincll and PstI cleavage, treatment with T4 DNA polymerase and religation. The HinclI [nucleotide (nO 7013 on the sequence map] -Bg111 (nt 7670) fragment of pCaMV 10 (Howarth et al., 1981) , containing the CaMV 35S promoter and terminator regions, was ligated into the SmaI/BamHI-cut modified pUC9 vector to create pC2. The plasmid pC2 was digested with HphI and made blunt-ended with T4 DNA polymerase. After additional digestion with EcoRI and HindlII, the 425 bp and 249 bp fragments were recovered from an agarose gel and ligated into HinclI/EcoRI-cut and SmaI/HindlII-cut pUC19 to create pC2P and pC2T, respectively. The EcoRI (nt 5647 to nt 6106) (Howarth et aL, 1981) fragment was cloned into EcoRI-cut pUC19, creating pCaEc4. The HindlII (nt 5849) (Howarth et al., 198 l) -PstI fragment of pCaEc4, containing a 0-2K fragment of CaMV DNA and the polylinker sequence between the Pst! and KpnI sites of pUC19, were cloned into the PstI/HindlII site of pC2P, creating pC33. The EcoRI-KpnI fragment of pC33, containing the promoter region and the polylinker sequence, was ligated with the large fragment of EcoRI/KpnI-cut pC2T, containing the termination region, creating pCAM35. The HindlII/EcoRI-cut fragment of pCAM35 was subcloned into the HindlII/EcoRI site of pUC119, creating pCAM35EP. To introduce a Stul site at the site of initiation of transcription of the 35S RNA promoter, a 25 base synthetic oligonucleotide 5' pd-(GTAGGCCTCTCCAAATGAAATGAAC), complementary to the promoter sequence with two mismatched bases and generating a StuI site, was annealed to ssDNA generated from pCAM35EP, dsDNA was (a) synthesized using the Klenow fragment of Escherichia coli DNA polymerase I. After digestion with Pvull, the DNA fragment was denatured by heating and separated by urea-PAGE (Maniatis et al., 1982) . ssDNA (458 nt) containing the modified sequence was recovered and second-strand DNA was synthesized by DNA polymerase using an M 13 reverse sequence primer (Takara Shuzo). A 431 bp fragment of the EcoRl-cut DNA was cloned into the EcoRI/SmaI site of pUC18, creating pCaP35.
Construction of pBICBRI, 2 and 3 and pUCBR1, 2 and 3. The small fragment of EcoRI/HindlII-cut pBIl01 (Clontech Laboratories) was replaced with the small fragment of EcoRI/HindlII-cut pCAM35, creating pBIC35. This plasmid was cut with EcoRI, made blunt-ended with T4 DNA polymerase and then then ligated with SalI linkers. The plasmids were cut with Sail and self-ligated, thus removing the promoter region. The resultant plasmid, pBICT(-E), was cut with SmaI and then ligated with EcoRI linkers 5' pd(GGAATTCC), creating pBICTE, pCaP35 was cut with EcoRI, blunt-ended with T4 DNA polymerase, ligated with Sail linkers and then cut with Sail and BamHI; the resulting small fragment was inserted into SalI/BamHl-cut pBICTE, creating pBICP35. This plasmid has Stul, BamHl, EcoRI and KpnI sites between the modified 35S promoter and terminator regions. Each cDNA fragment of SnaBI/EcoRI-cut pBB1, pBB2 and pBB3 was inserted into StuUEcoRI-cut pBICP35, creating pBICBR1, 2 and 3, respectively (Fig. 2) . The small fragment of pBICP35, cut with Sail, blunt-ended with T4 DNA polymerase and then cut with HindlII, (Fig. 2) .
Construction of pUCBRIR1, 2 and 3.
Each SnaBI/EcoRI-cut cDNA fragment of pBBI, 2 and 3 was inserted into BamHI/EcoRI-cut pUCP35, after making the BamHI site blunt-ended, creating pUC-BRIR1, 2 and 3, respectively (Fig. 2) .
Construction ofpBTFIR1. Synthetic nucleotides containing the T7
promoter, 5' pd(AGCTTAAATTAATACGACTCACTATAGG-TAC) and 5' pd(CTATAGTGAGTCGTATTAATTTA), were annealed and inserted into KpnI/HindlII-cut pUC18, creating pUCTG. pUCBRIR1 was cut with StuI and EcoRI and the cDNA fragment was inserted into KpnI/EcoRI-cut pUCTG, after making the KpnI site blunt-ended, creating pBTFIR1 (Fig. 2) .
In vitro transcription. Template DNA linearized with EcoRI (2 p.g) was incubated in a 100 Ixl reaction mixture containing 40 mM-Tris-HCl pH 7-5, 6 mM-MgCI2, 2 mM-spermidine, 10 mM-NaC1, 10 mM-DTT, 0.5 mM each of ATP, CTP and UTP, 70 IxM-GTP, 0.5 mMmTGpppG (New England Biolabs), 2000 units/ml RNasin (Promega Biotec) and 400 units/ml T7 RNA polymerase (Takara Shuzo). After 60 min, mTGpppG and T7 RNA polymerase were added to the mixture to give final concentrations of 430 ~tM and 400 units/ml, respectively, and incubation was continued for a further 60 min; template DNA was then digested by the addition of DNase I (Promega Biotec) directly to the reaction mixture (1 unitAtg template) and incubation for 15 min. Transcripts were extracted once with phenol/chloroform and once with chloroform and recovered by sodium acetate-ethanol precipitation.
Infectivity. Transcript RNA synthesized from EcoRI-linearized pBTF and pBTFIR by T7 RNA polymerase in the presence of mTGpppG was inoculated onto the first leaves of barley (Hordeum vulgate L. cv. Goseshikoku) or Carborundum-dusted leaves of Chenopodium hybridum. Local lesions were counted 8 days postinoculation. Plasmid DNA of pBICBR and pUCBR prepared from E.
coli was treated with 25 ~tg/ml RNase at 37 °C for 1 h, extracted twice with phenol-chloroform and precipitated with ethanol. The precipitate was suspended in 0.4 M-NaCI, 6.5 % polyethylene glycol (M r 6000) and placed on ice for 1 h. After centrifugation and washing with 70% ethanol, each precipitated DNA was resuspended in sterilized water and mixed to give the concentrations indicated in Table 1 . The mixtures of DNAs were inoculated onto the leaves of barley and C. hybridum as described above.
Measurement of virus content of local lesions. Ten local lesions excised
from leaves inoculated with each tested sample were individually mixed and homogenized in 100 ~tl 100 raM-acetate pH 5.0 containing 10 mM-MgC12. The homogenate was diluted appropriately and inoculated onto C. hybridum.
Results

Construction of the full-length cDNA of BMV genornic RNAs
When transcript RNAs from pBTF1, 2 and 3 were inoculated onto the first leaves of barley, mosaic symptoms appeared 7 days later in the basal parts of the second leaf. This indicates that pBTF contained full length biologically active cDNAs of BMV RNAs.
Infectivity of plasmids pBICBR and pUCBR
pBICBR1, 2 and 3 were extracted from E. coli, mixed and inoculated onto C. hybridum at a final concentration of 1 ~tg/Ixl. Necrotic lesions formed on the inoculated leaves 6 days later. To prepare large amounts of plasmid DNA from E. coli the 35S promoter and terminator regions containing BMV cDNA were subcloned in pUC 18 to create pUCBR1, 2 and 3. These plasmids were infectious to C. hybridum. The infectivity of such plasmids disappeared after treatment with DNase but not RNase. This confirmed that the infectivity was due to the plasmid DNA. No systemic symptoms appeared in 20 barley plants inoculated with plasmids at a concentration of 1 ~tgAtl. Neither pBB1, 2 and 3 nor pBTFI, 2 and 3 were infectious to either plant species.
Properties of pUCBR1, 2 and 3
A mixture of pUCBR1, 2 and 3 had about 1% of the infectivity ofBMV RNA (Table 1) . Although viral RNA having a non-viral sequence of more than 5 bases at the 5' end was not infectious (Janda et al., 1987) or poorly infectious (Table 1) , plasmids which had an extra 12 bases (CCTACGGGGATC) at the 5' ends of the cDNA inserts were infectious and induced local lesion formation in C. hybridum leaves. In contrast, mixtures of pUCBRIR1 with pUCBR2+3, pUCBRIR2 with pUCBR1 +3 and pUCBRIR3 with pUCBR1 +2 had specific infectivities of about 50 % that of the homologus mixtures of pUCBR1, 2 and 3 (Table 1 ). Local lesions induced by plasmid inocula were indistinguishable from those induced by BMV in appearance and in their virus content. However, lesions induced by DNA plasmid inocula became apparent about 24 h later than those induced by virus RNA. The delay is possibly explained by the time required for plasmid DNAs to be transferred to cell nuclei and for host RNA polymerase to synthesize transcripts.
Discussion
It is known that cDNAs of the genomic RNA of poliovirus (Racaniello & Baltimore, 1981) , satellite tobacco necrosis virus (van Emmelo et al., 1987) , Qfl phage (Taniguchi et al., 1978) and potato spindle tuber viroid (Cress et al., 1983) inserted into bacterial plasmids are infectious, although the infectious RNAs seem to be transcribed from the cDNAs by an unknown promoter. In our experiments, bacterial plasmids containing the cDNAs of BMV RNAs (pUCBR1, 2 and 3) were infectious to C. hybridum when the cDNA was joined upstream to the promoter sequence of CaMV 35S RNA. This indicates that the mechanically inoculated plasmid DNA was introduced into C. hybridum ceils and that BMV RNAs were produced by transcription of the cDNAs from the promoter in the cells; no virus was detected after inoculation with pBTF1, 2 and 3, which contained the bacteriophage T7 promoter instead of the CaMV 35S promoter. Nuclease sensitivity tests showed that the infectivity was not due to viral RNA contaminating the pUCBR1, 2 and 3 DNAs. It is not surprising that a DNA copy of an RNA virus genome inserted into a plasmid with a functional promoter for eukaryotic cells can initiate the infection process. However, the virus sense RNA strands would probably have extra non-viral sequences at their 3' ends and, in the case ofpUCBRIR1, 2 and 3, also at the 5' end. Precisely how these molecules replicate is not clear; the extra sequence might be randomly cleaved off by nuclease or not removed at all. In the latter case, replication might occur by the recognition of an internal initiation site by the viral replicase. In contrast, transcripts with more than five bases at the 5' end were not infectious (Janda et al., 1987) . Although we have not yet characterized the primary transcripts, the first transcripts with extra sequences at either or both ends would be quickly altered so that the terminal sequences were like those of wild-type BMV, because the infectivity of an extract of a local lesion induced by plasmid DNA was almost the same as that of an extract of a lesion induced by BMV RNA.
The plasmid DNA system used in these experiments has several advantages over an RNA system using transcripts as inoculum. These are (i) transcripts are continuously provided from cDNA in the nucleus of the inoculated cells, (ii) the DNA system does not require that the 5' and 3' ends of the inserted cDNA sequence be as precise as when synthesizing in vitro transcripts and (iii) with plasmid DNA there is no requirement for the use of cap structures.
